Use of Tachosil® as an adjuvant therapeutic option in neurotrophic keratopathy in order to prevent perforation

0Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We present two cases of women who suffered from neurotrophic keratopathy (one of them had undergone penetrating keratoplasty) which had led to corneal thinning. Tachosil® was used as an adjuvant treatment after topical medication by itself failed in both cases. To our knowledge, there are no reported cases of the use of Tachosil® in corneal grafts.

Cite

CITATION STYLE

APA

Rahhal-Ortuño, M., Fernández-Santodomingo, A., Molina-Pallete, R., Hurtado-Sarrió, M., & Cisneros-Lanuza, Á. (2019). Use of Tachosil® as an adjuvant therapeutic option in neurotrophic keratopathy in order to prevent perforation. Indian Journal of Ophthalmology, 67(7), 1198–1200. https://doi.org/10.4103/ijo.IJO_1573_18

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free